BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28078909)

  • 1. Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues.
    Mariampillai JE; Eskås PA; Heimark S; Larstorp AC; Fadl Elmula FE; Høieggen A; Nortvedt P
    Blood Press; 2017 Jun; 26(3):133-138. PubMed ID: 28078909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Refractory hypertension].
    Os I; Eide IK; Westheim AS; Kjeldsen SE
    Tidsskr Nor Laegeforen; 1995 Feb; 115(6):723-4. PubMed ID: 7900136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to medication and drug monitoring in apparent treatment-resistant hypertension.
    Eskås PA; Heimark S; Eek Mariampillai J; Larstorp AC; Fadl Elmula FE; Høieggen A
    Blood Press; 2016 Aug; 25(4):199-205. PubMed ID: 26729283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications.
    Harmon G; Lefante J; Krousel-Wood M
    Curr Opin Cardiol; 2006 Jul; 21(4):310-5. PubMed ID: 16755199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients.
    Krousel-Wood M; Thomas S; Muntner P; Morisky D
    Curr Opin Cardiol; 2004 Jul; 19(4):357-62. PubMed ID: 15218396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [No response to antihypertensive therapy: consider non-adherence].
    Braam RL; Van Uum SH; Lenders JW; Thien T
    Ned Tijdschr Geneeskd; 2007 Mar; 151(10):569-73. PubMed ID: 17402645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming barriers to effective blood pressure control in patients with hypertension.
    Düsing R
    Curr Med Res Opin; 2006 Aug; 22(8):1545-53. PubMed ID: 16870079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study.
    van Onzenoort HA; Menger FE; Neef C; Verberk WJ; Kroon AA; de Leeuw PW; van der Kuy PH
    Hypertension; 2011 Oct; 58(4):573-8. PubMed ID: 21825228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to improve adherence with prescribed treatment in hypertensive patients?
    Waeber B; Burnier M; Brunner HR
    J Cardiovasc Pharmacol; 2000; 35 Suppl 3():S23-6. PubMed ID: 10854048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to assess and to improve adherence in clinical practice?].
    Márquez Contreras E; Márquez Rivero S; Rodríguez García E; Baldonedo Suárez A
    Hipertens Riesgo Vasc; 2017 Jan; 34 Suppl 1():29-35. PubMed ID: 29703400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication.
    Tamblyn R; Abrahamowicz M; Dauphinee D; Wenghofer E; Jacques A; Klass D; Smee S; Eguale T; Winslade N; Girard N; Bartman I; Buckeridge DL; Hanley JA
    Arch Intern Med; 2010 Jun; 170(12):1064-72. PubMed ID: 20585073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting medication adherence in hypertensive patients.
    Patel RP; Taylor SD
    Ann Pharmacother; 2002 Jan; 36(1):40-5. PubMed ID: 11816255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and management of hypertensive patients in clinical practice: Cross-sectional registry in five countries outside the European Union.
    Ragot S; Beneteau M; Guillou-Bonnici F; Herpin D
    Blood Press; 2016; 25(2):104-16. PubMed ID: 26873621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing 'resistance': is adherence a target for treatment?
    Burnier M
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):439-43. PubMed ID: 25036746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence and resistant hypertension.
    Hyman DJ; Pavlik V
    J Hum Hypertens; 2015 Apr; 29(4):213-8. PubMed ID: 25209307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 18. Shared decision making in hypertension: the impact of patient preferences on treatment choice.
    Montgomery AA; Harding J; Fahey T
    Fam Pract; 2001 Jun; 18(3):309-13. PubMed ID: 11356740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' ability to predict patients' adherence to antihypertensive medication in primary care.
    Zeller A; Taegtmeyer A; Martina B; Battegay E; Tschudi P
    Hypertens Res; 2008 Sep; 31(9):1765-71. PubMed ID: 18971555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.